Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6244357 | European Journal of Radiology | 2012 | 6 Pages |
Abstract
Natalizumab reduced relapse rate and CEL in MRI. Brain atrophy predominated in the first semester and was related to previous inflammatory activity.
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
M. Magraner, F. Coret, B. Casanova,